News | January 06, 2026
PHARMEXCIL holds high-level talks with government to boost India’s pharma exports
India’s pharmaceutical sector stands at a pivotal inflection point
India’s pharmaceutical sector stands at a pivotal inflection point
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Mehta is an industry veteran with over 25 years of experience in the pharmaceutical industry
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
The event is supported by the Ministry of Commerce & Industry, Government of India and CDSCO, Ministry of Health.
The event will include an exhibition and sector-wise sessions for two days with participation by officials from the Ministry of Commerce, export promotion councils and members of the industry
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
Subscribe To Our Newsletter & Stay Updated
